Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Eliquent Appoints Rob Wojciechowski As Chief Operating Officer

PRIVATEFeb 04, 2025•over 1 year ago

Position

Managing Director

Company

ELIQUENT Life Sciences

Rob Wojciechowski

WashingtonBiotechnologyHealth CareVenture Capital

Description

ELIQUENT Life Sciences has appointed Rob Wojciechowski as the Chief Operating Officer (COO), who will be responsible for strategic initiatives in the areas of regulatory, quality, and compliance consulting. Rob brings extensive leadership and strategic consulting background, and he will work closely with the ELIQUENT leadership team to strengthen the company's global influence and expand its service offerings while ensuring seamless integration of regulatory, quality, and compliance solutions.

Company Information

Company

ELIQUENT Life Sciences

Location

Washington, District Of Columbia, United States

About

ELIQUENT Life Sciences is a leading global consulting group delivering regulatory affairs, pharmacovigilance, quality, and compliance solutions that support clients across therapeutic modalities, phase-based pathways, and major global markets. The firm's unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly to deliver the global solutions that pharmaceutical, biotechnology, and medical device companies need to bring new therapies to gain and maintain market authorization for their products. ELIQUENT’s continued growth is supported by GHO Capital, the European specialist investor in healthcare.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for ELIQUENT Life Sciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months